Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 study of hOMSC200 for chronic non-healing diabetic foot ulcers
MOH_2021-11-28_010339Phase 2Recruiting
- Sponsor
- Cytora
- Start
- Jan 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of hOMSC200 in diabetic foot ulcer (DFU) (3 arms), sponsored by Cytora. Started Jan 2020; status: recruiting.
02
Drugs
hOMSC200
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on MOH_2021-11-28_010339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-11-28_010339.